Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating non-invasive intermittent theta burst stimulation of the dorsolateral prefrontal cortex for functional movement disorder; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Functional Movement Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING